World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
119
Citations
67274
World Ranking
3834
National Ranking
2099

Research.com Recognitions

  • 1993 - Kelly West Award, American Diabetes Association

Overview

Trevor J. Orchard is affiliated with the University of Pittsburgh in the United States and has an extensive publication record in the field of medicine, particularly focusing on endocrinology, diabetes, and metabolism. Their research spans multiple subfields including cardiology and cardiovascular medicine, genetics, surgery, and molecular biology.

The scientist's work prominently covers several interconnected topics such as diabetes management and research, diabetes treatment and management, diabetes and associated disorders, and the relationship between diabetes, cardiovascular risks, and lipoproteins. Further areas of focus include pancreatic function related to diabetes, cardiovascular health and risk factors, as well as cardiovascular function and risk factors.

Among their recent papers are:

  • Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study (2022) published in The Lancet Diabetes & Endocrinology
  • Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study (2020) published in Diabetes
  • Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study (2022) published in Circulation
  • Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study (2020) published in Diabetes Care
  • Understanding Metabolic Memory: A Tale of Two Studies (2020) published in Diabetes

Trevor J. Orchard has frequently collaborated with several coauthors, including Rachel G. Miller, Tina Costacou, Samar R. El Khoudary, Maria M. Brooks, and Karen A. Matthews. These collaborations have contributed to a substantial body of work, particularly in journals such as Diabetes, Diabetes Care, Circulation, Journal of Diabetes and its Complications, and Diabetologia.

  • Diabetes
  • Diabetes Care
  • Circulation
  • Journal of Diabetes and its Complications
  • Diabetologia

Trevor J. Orchard's research contributions are recognized in the academic community, including receiving the Kelly West Award from the American Diabetes Association in 1993.

Best Publications

  • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

    David M. Nathan;Patricia A. Cleary;Jye Yu C Backlund;Saul M. Genuth

  • Global Prevalence and Major Risk Factors of Diabetic Retinopathy

    Joanne W.Y. Yau;Sophie L. Rogers;Ryo Kawasaki;Ecosse L. Lamoureux;Ecosse L. Lamoureux

  • A randomized trial of therapies for type 2 diabetes and coronary artery disease.

    L. Frye;Phyllis August;Regina M. Hardi;Sheryl F. Kelsey

  • The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Trevor J. Orchard;Marinella Temprosa;Ronald Goldberg;Steven Haffner

  • Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

    David M Nathan;John Lachin;Patricia Cleary;Trevor Orchard

  • Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study

    D. M. Nathan;E. Barrett-Connor;J.P. Crandall

  • Effect of lipid reduction on the progression of renal disease: A meta-analysis

    Linda F. Fried;Linda F. Fried;Trevor J. Orchard;Trevor J. Orchard;Bertram L. Kasiske;Bertram L. Kasiske

  • Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

    Sarah D. de Ferranti;Ian H. de Boer;Vivian Fonseca;Caroline S. Fox

  • Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

    Robert Ratner;Ronald Goldberg;Steven Haffner;Santica Marcovina

  • Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II

    Trevor J Orchard;Janice S Dorman;Raelene E Maser;Dorothy J Becker

  • Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

    Thomas J. Hoerger;Albert D. Bethke;Anke Richter;Stephen W. Sorensen

  • Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study

    Trevor J. Orchard;Jon C. Olson;John R. Erbey;Katherine Williams

  • The 30-year natural history of type 1 diabetes complications : The pittsburgh epidemiology of diabetes complications study experience

    Georgia Pambianco;Tina Costacou;Demetrius Ellis;Dorothy J. Becker

  • Can clinical factors estimate insulin resistance in type 1 diabetes

    Katherine V. Williams;John R. Erbey;Dorothy Becker;Silva Arslanian

  • Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

    Prabhakara R. Nagareddy;Andrew J. Murphy;Roslynn A. Stirzaker;Yunying Hu

  • Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years’ Duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005)

    Diabetes Control;Complications Trial;Complications (Dcct)

  • Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

    Vanita R. Aroda;Sharon L. Edelstein;Ronald B. Goldberg;William C. Knowler

  • The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS

    W. H. Herman;S. L. Edelstein;R. E. Ratner;Maria G Montez

  • Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

    Anne Katrin Sjølie;Ronald Klein;Massimo Porta;Trevor Orchard

  • Global prevalence and major risk factors of diabetic retinopathy.

    Olubukola Ajala;Patrick English;Jonathan Pinkney;Joanne W Y Yau

Frequent Co-Authors

Dorothy J. Becker
Dorothy J. Becker University of Pittsburgh
Ronald E. LaPorte
Ronald E. LaPorte University of Pittsburgh
Lewis H. Kuller
Lewis H. Kuller University of Pittsburgh
John M. Lachin
John M. Lachin George Washington University
Ronald Klein
Ronald Klein University of Wisconsin–Madison
Sheryl F. Kelsey
Sheryl F. Kelsey University of Pittsburgh
Robert E. Ratner
Robert E. Ratner Georgetown University
David M. Nathan
David M. Nathan Harvard University
Christopher M. Ryan
Christopher M. Ryan University of Pittsburgh
Caterina Rosano
Caterina Rosano University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens a range of related options in healthcare and health sciences. For those interested in flexible learning, numerous online degrees make it easier to start or advance your career without relocating.

If you want to enter the healthcare field quickly and affordably, consider exploring the cheapest online health science degree programs. These degrees offer a solid foundation for many entry-level positions.

For those looking to move into management, a masters in healthcare administration cost is a critical factor when considering further study. These online master’s programs provide key administrative and leadership skills needed in today’s healthcare environment.

Nursing professionals hoping to take their careers to the highest level can discover the cheapest bsn to dnp programs, which allow for advanced clinical practice and leadership opportunities.

Pharmacists in training can also benefit from flexible online options. Accredited pharm d online programs help students balance work and study while preparing for professional licensure.

Each of these pathways paves the way for rewarding roles within the dynamic healthcare industry.

Best Scientists Citing Trevor J. Orchard

Trending Scientists

Recently Published Articles